Company · CIK 1853921

# Scribe Therapeutics, Inc.

| CIK | [1853921](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001853921) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | SCTX (Nasdaq) |
| First annual or quarterly report | 2026-09-02 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-297246 | IPO Final prospectus | 2026-07-02 | 2026-07-27 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-07-27 | [424B4](https://www.sec.gov/Archives/edgar/data/1853921/000119312526316503/0001193125-26-316503-index.htm) Final prospectus | 333-297246 | 0001193125-26-316503 |
| 2026-07-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1853921/999999999526002417/9999999995-26-002417-index.htm) Declared effective | 333-297246 | 9999999995-26-002417 |
| 2026-07-20 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/0001193125-26-308330-index.htm) Amendment | 333-297246 | 0001193125-26-308330 |
| 2026-07-10 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1853921/000119312526300994/0001193125-26-300994-index.htm) Amendment | 333-297246 | 0001193125-26-300994 |
| 2026-07-02 | [S-1](https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/0001193125-26-294804-index.htm) Registration filed | 333-297246 | 0001193125-26-294804 |
| 2026-01-09 | [DRS](https://www.sec.gov/Archives/edgar/data/1853921/000119312526009106/0001193125-26-009106-index.htm) Draft made public | 377-08928 | 0001193125-26-009106 |

[All filings of this company](https://equitycapital.markets/filings?cik=1853921) · [CSV](https://equitycapital.markets/filings.csv?cik=1853921)

---
Source page: https://equitycapital.markets/company/1853921 · Data: U.S. SEC EDGAR · CC BY 4.0